• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Syncor signs with Broadlane

Article

Radiopharmacy giant Syncor International has cut a new three-year agreement and two-year renewal option with Broadlane, a major provider of supply chain services to the healthcare industry. The agreement, which takes effect immediately, establishes

Radiopharmacy giant Syncor International has cut a new three-year agreement and two-year renewal option with Broadlane, a major provider of supply chain services to the healthcare industry. The agreement, which takes effect immediately, establishes Syncor as the distributor of radiopharmaceuticals, including FDG, to Broadlane’s 572 acute care hospitals and 2335 subacute healthcare facilities. In addition to the sole source agreement, Broadlane will also make available to its members Syncor’s PharmaSeed I-125 brachytherapy seeds.

Related Videos
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.